Stage IIIB Lung Non-Small Cell Cancer AJCC v7 Completed Phase 3 Trials for Sunitinib (DB01268)

IndicationStatusPhase
DBCOND0115716 (Stage IIIB Lung Non-Small Cell Cancer AJCC v7)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00693992Sunitinib Malate as Maintenance Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Previously Treated With Combination ChemotherapyTreatment